| Literature DB >> 35916989 |
Ashley Zhou1, Sally S Ong1, Ishrat Ahmed1, J Fernando Arevalo1, Cindy X Cai1, James T Handa2.
Abstract
While socioeconomic disparities impact clinical care and patient outcomes, their impact on the anatomic and visual outcomes of retinal detachment in patients with viral retinitis is unstudied. This case series included 18 eyes in 18 patients from a single academic institution between January 1, 2008 and December 31, 2018. Patient characteristics including age, sex, race, ethnicity, insurance, immunosuppression, viral retinitis, retinal detachment, retinal detachment repair, visual and anatomic outcomes, missed appointments, and Area Deprivation Index [ADI] were collected. The low-ADI group, indicating less socioeconomic disadvantage, was comprised of twelve patients with national ADIs less than 38, and the high-ADI group of six patients with national ADIs greater than 38. High-ADI patients tended to be younger (average age 38.0 versus 51.3; P = 0.06), of female sex (P = 0.03), and had more missed appointments (median 11.0 vs 0; P = 0.002). A similar number of patients in both the high-ADI and low-ADI groups underwent pars plana vitrectomy alone or pars plana vitrectomy with scleral buckle. Visual acuity was similar in the high-ADI group than in the low-ADI group at baseline, but worse at the final follow-up visit (P = 0.004). Post-operative and final visit ocular hypotony were more common in the high-ADI group (P = 0.02). In our series, socioeconomic disadvantage negatively affects the visual outcomes in patients with viral retinitis associated-retinal detachments. These factors should be considered by ophthalmologists when treating these patients.Entities:
Keywords: Area deprivation index; Retinal detachment; Social determinants of health; Viral retinitis
Year: 2022 PMID: 35916989 PMCID: PMC9346012 DOI: 10.1186/s12348-022-00303-4
Source DB: PubMed Journal: J Ophthalmic Inflamm Infect ISSN: 1869-5760
Characteristics of all patients with viral retinitis
| Case | Age (y)/ Sex | National ADI | ADI group | Insurance type | Missed appointments | Bilateral retinitis | Bilateral RD | Cause of immune dysfunction | Causative virus | Zonal classification | Area of viral retinitis (DAs) | Type of primary surgery | Tamponade |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 59/F | 3 | Low | No insurance | 1 | Yes | No | N/A | HSV | 2, 3 | > 34 | PPV | Silicone oil |
| 2 | 42/F | 6 | Low | Private | 0 | No | No | N/A | HSV | 3 | 4 | PPV/SB | SF6 |
| 3 | 65/M | 11 | Low | Medicare | 0 | No | No | Chronic Lymphocytic Leukemia | HSV | 2, 3 | 12 | PPV/SB | Silicone oil |
| 4 | 50/F | 15 | Low | Private | 0 | Yes | No | Transplantation, Myelodysplastic syndrome | CMV | 3 | N/A | PPV | SF6 |
| 5 | 29/M | 22 | Low | Public | 0 | No | No | HIV | CMV | 1, 2, 3 | 22 | PPV | Silicone oil |
| 6 | 39/M | 24 | Low | Public | 2 | Yes | Yes | HIV | CMV | 2, 3 | 18 | PPV/SB | Silicone oil |
| 7 | 59/M | 26 | Low | Private | 3 | Yes | No | HIV | CMV | 3 | 6 | PPV | SF6 |
| 8 | 69/F | 27 | Low | Medicare | 3 | No | No | Non-Hodgkin’s Lymphoma | CMV | 3 | 6 | PPV/SB | C3F8 |
| 9 | 82/M | 28 | Low | Private | 0 | No | No | Steroids, Sarcoidosis | CMV | 3 | 4 | PPV | SF6 |
| 10 | 37/F | 33 | Low | Private | 0 | No | No | HIV | CMV | 2, 3 | 22 | SB | N/A |
| 11 | 52/F | 34 | Low | Private | 0 | Yes | Yes | Steroids | HSV | 3 | > 30 | PPV/SB | Silicone oil |
| 12 | 50/M | 34 | Low | Private | 1 | Yes | Yes | N/A | VZV | 3 | 34 | PPV/SB | SF6 |
| 13 | 44/F | 43 | High | Medicare | 1 | Yes | Yes | HIV | CMV | 2 | 12 | PPV | Silicone oil |
| 14 | 36/F | 50 | High | Medicare | 14 | Yes | Yes | HIV | CMV | 3 | 8 | PPV/SB | SF6 |
| 15 | 40/F | 58 | High | Public | 12 | Yes | No | HIV | CMV | 1, 2, 3 | > 30 | PPV | Silicone oil |
| 16 | 44/F | 77 | High | Public | 13 | Yes | No | HIV | CMV | 3 | > 34 | PPV/SB | Silicone oil |
| 17 | 32/F | 91 | High | Public | 10 | No | No | N/A | CMV | 2 | 4 | PPV | Silicone oil |
| 18 | 32/F | 99 | High | Medicare | 10 | Yes | Yes | HIV | VZV | 3 | N/A | PPV/SB | Silicone oil |
ADI Area Deprivation Index, HIV human immunodeficiency virus, SLE systemic lupus erythematosus, CMV cytomegalovirus, HSV herpes simplex virus, VZV varicella zoster virus, DAs disc areas, PPV pars plana vitrectomy, SB scleral buckle, PPV/SB pars plana vitrectomy with scleral buckle, SF sulfur hexafluoride, CF perfluoropropane
Baseline demographics
| High ADI | Low ADI | ||
|---|---|---|---|
| Number of patients | 6 | 12 | |
| Age at diagnosis of viral retinitis, mean (SD) | 38.0 (5.5) | 51.3 (15.2) | 0.06 |
| Sex | |||
| Male | 0 (0%) | 6 (50%) | 0.03 |
| Female | 6 (100%) | 6 (50%) | |
| Race | |||
| White | 1 (17%) | 5 (42%) | 0.27 |
| Black | 5 (83%) | 5 (42%) | |
| Not reported | 0 (0%) | 2 (17%) | |
| Insurance type | |||
| Private | 0 (0%) | 7 (58%) | 0.07 |
| Public | 3 (50%) | 2 (17%) | |
| Medicare | 3 (50%) | 2 (17%) | |
| No insurance | 0 (0%) | 1 (8%) | |
| Lost to follow-up | 1 (17%) | 4 (33%) | 1.00 |
| Missed appointments, median (IQR) | 11.0 (7.8, 13.3) | 0.0 (0.0, 1.8) | 0.009 |
| Missed appointments due to transportation issues | 5 (83%) | 4 (33%) | 0.13 |
| Bilateral viral retinitis | 5 (83%) | 6 (50%) | 0.32 |
| Bilateral viral retinitis-associated RD | 3 (50%) | 3 (25%) | 0.34 |
| Cause of immune dysfunction | |||
| Medications | 0 (0%) | 1 (8%) | 0.96 |
Malignancy Chronic Lymphocytic Leukemia | 0 (0%) | 1 (8%) | |
| Non-Hodgkin’s Lymphoma | 0 (0%) | 1 (8%) | |
| HIV | 5 (83%) | 4 (33%) | |
Systemic Disorder Myelodysplastic syndrome | 0 (0%) | 1 (8%) | |
| Sarcoidosis | 0 (0%) | 1 (8%) | |
| None | 1 (17%) | 3 (25%) | |
| Patients with HIV | 5 (83%) | 4 (33%) | 0.13 |
| Causative virus | |||
| HSV | 0 (0%) | 4 (33%) | 0.31 |
| VZV | 1 (17%) | 1 (8%) | |
| CMV | 5 (83%) | 7 (58%) | |
| Area of viral retinitis (DAs), mean (SD) | 17.6 (11.8) | 17.5 (13.5) | 0.99 |
ADI Area Deprivation Index, RD retinal detachment, HIV human immunodeficiency virus, CMV cytomegalovirus, HSV herpes simplex virus, VZV varicella zoster virus, DAs disc areas
Retinal detachment and surgical repair characteristics
| High ADI ( | Low ADI ( | ||
|---|---|---|---|
| Viral retinitis active at time of RD | 5 (83%) | 7 (58%) | 0.60 |
| Macular involvement | 4 (67%) | 4 (33%) | 0.32 |
| Foveal involvement | 2 (33%) | 3 (25%) | 1.00 |
| Proliferative vitreoretinopathy | 3 (50%) | 3 (25%) | 0.34 |
| Type of primary surgery | |||
| PPV | 3 (50%) | 6 (50%) | 1.00 |
| PPV/SB | 3 (50%) | 5 (42%) | |
| SB | 0 (0%) | 1 (8%) | |
| Other adjuncts | |||
| Endolaser | 6 (100%) | 11 (92%) | 1.00 |
| Cryotherapy | 0 (0%) | 1 (8%) | |
| Membrane Peeling | 3 (50%) | 5 (42%) | 0.62 |
| Tamponade | |||
| SF6 | 1 (17%) | 5 (42%) | 0.51 |
| C3F8 | 0 (0%) | 1 (8%) | |
| Silicone oil | 5 (83%) | 5 (42%) | |
| None | 0 (0%) | 1 (8%) | |
| Silicone oil removal | 1 (20%) | 4 (80%) | 0.21 |
| Time to silicone oil removal, median (IQR) | 3.0 | 6.5 (5.0, 8.0) | 0.13 |
| Phacoemulsification + IOL during silicone oil removal | 1 (17%) | 2 (17%) | 0.31 |
ADI Area Deprivation Index, RD Retinal detachment, PPV pars plana vitrectomy, PPV/SB pars plana vitrectomy with scleral buckle, SB scleral buckle, SF sulfur hexafluoride, CF perfluoropropane, IOL intraocular lens
Anatomic and visual outcomes
| High ADI ( | Low ADI ( | ||
|---|---|---|---|
| Re-detachment at six months | 0 (0%) | 1 (8%) | 0.06 |
| Re-detachment over follow up | 1 (17%) | 3 (25%) | 0.27 |
| VA LogMAR equivalent, median (IQR) | |||
| Baseline | 1.2 (1.0, 2.7) | 0.7 (0.1, 2.3) | 0.12 |
| 6-month post-op | 1.2 (0.9, 2.1) | 0.7 (0.5, 1.1) | 0.13 |
| 1-year post-op | 1.1 (0.8, 2.6) | 0.5 (0.2, 0.8) | 0.05 |
| Final follow-up | 2.6 (2.3, 3.2) | 0.7 (0.3, 1.0) | 0.004 |
| VA changes between baseline and final follow-up | |||
| Gained 15 + letters | 1 (17%) | 4 (33%) | 0.41 |
| Gained 10–14 letters | 0 (0%) | 1 (8%) | |
| Gained/lost less than 9 letters | 0 (0%) | 3 (25%) | |
| Lost 10–14 letters | 1 (17%) | 1 (8%) | |
| Lost 15 + letters | 4 (67%) | 3 (25%) | |
ADI Area Deprivation Index, VA visual acuity
Postop complications
| High ADI ( | Low ADI ( | ||
|---|---|---|---|
| Hypotonic intraocular pressure (< 5 mm Hg) | 4 (67%) | 1 (8%) | 0.02 |
| Cystoid macular edema | 1 (17%) | 5 (42%) | 1.00 |
| Macular pucker | 2 (33%) | 3 (25%) | 1.00 |
| Optic atrophy | 1 (17%) | 1 (8%) | 1.00 |
| Cataract present before surgery | 5 (83%) | 2 (17%) | 0.02 |
| Cataract formation after surgery | 0 (0%) | 5 (42%) | 0.11 |
| Timing cataract surgery after primary RD repair, median (IQR) | 3.0 | 7.5 (6.0, 10.0) | 0.16 |
ADI Area Deprivation Index, RD retinal detachment